Upstream Bio, Total Other Income Expense Net Over Time
| UPB Stock | 18.35 2.05 12.58% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Upstream Bio, Performance and Upstream Bio, Correlation. Upstream |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Other Income Expense Net Analysis
Compare Upstream Bio, and related stocks such as United Parks Resorts, Dave Busters Enterta, and Chemours Total Other Income Expense Net Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRKS | (171.7 M) | (171.7 M) | (171.7 M) | (171.7 M) | (96.7 M) | (88.9 M) | (111.9 M) | (368.4 M) | (118.5 M) | (123.2 M) | (101.2 M) | (175.6 M) | (117.5 M) | (146.6 M) | (168.6 M) | (177.1 M) |
| PLAY | (22.1 M) | (44.9 M) | (47.6 M) | (47.8 M) | (27.6 M) | (6.8 M) | (148 K) | (957 K) | (58 K) | (20.9 M) | (37.8 M) | (59.5 M) | (88.8 M) | (143.5 M) | (129.2 M) | (122.7 M) |
| CC | 176 M | 176 M | 26 M | 44 M | 18 M | (282 M) | 106 M | 55 M | 118 M | (295 M) | (268 M) | (6 M) | (45 M) | (226 M) | (203.4 M) | (193.2 M) |
| SXT | 1.5 M | (19.4 M) | (16.9 M) | (16.1 M) | (16.1 M) | (16.9 M) | (18.3 M) | (19.4 M) | (21.9 M) | (20.1 M) | (14.8 M) | (12.5 M) | (14.5 M) | (25.2 M) | (22.7 M) | (23.8 M) |
| SONO | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | (2.2 M) | 3.4 M | (1.2 M) | (2.5 M) | (1.5 M) | 2 M | (20.8 M) | 24.9 M | 20.9 M | 24 M | 25.2 M |
| HWKN | 400 K | 145 K | 84 K | (29 K) | 38 K | (805 K) | (2.6 M) | (39 M) | 73 K | (204 K) | (27 K) | (1.2 M) | (5.6 M) | (2.9 M) | (2.6 M) | (2.5 M) |
| ALB-PA | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (59.2 M) | (307.4 M) | 78 M | 182.1 M | 209.4 M | 219.9 M |
Upstream Bio, and related stocks such as United Parks Resorts, Dave Busters Enterta, and Chemours Total Other Income Expense Net description
My Equities
My Current Equities and Potential Positions
| Upstream Bio, | UPB |
Specialization | Healthcare, Biotechnology |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
null 18.35
Check out Upstream Bio, Performance and Upstream Bio, Correlation. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Upstream Bio, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.